Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/01/039677
CTRI/2022/01/039677
Not yet recruiting
Phase 3

Interventional study to determine efficacy, safety and immunogenicity of booster dose of ChAdOx1 nCoV-19 (COVISHIELD) Coronavirus Disease (COVID-19) vaccine in vaccine recipients.- A single centre, randomised control trial - COVIBOOST

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Institute of Liver and Biliary Sciences
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Healthy volunteers above 18 years who have received 2 doses of ChAdOx1 nCoV\-19 vaccine
  • •Able and willing to comply with study requirements
  • •Willing to refrain from blood donation during the study period
  • •giving consent

Exclusion Criteria

  • •Anaphylactic reaction following administration of vaccine previously
  • •Pregnant or lactating women
  • •Any adverse event that in the opinion of the Investigator may affect the safety of the participant or the interpretation of the study results
  • •Subject not giving consent
  • •Individuals who have received any other COVID1\-9 vaccine

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
on-interventional study on the safety and efficacy of an Abraxane(R) mono therapy for the therapy of patients with metasasized breast cancer with special consideration of the toxicity profilesC50Malignant neoplasm of breast
DRKS00003203OnkoDataMed GmbH !450
Recruiting
Not Applicable
on-interventional study about safety and efficacy of chemo-therapy with Paclitaxel Stragen(R) / Eurotaxel(R) (new name of the prescription) as mono or combined therapy for routine treatment of ovarial or breast cancer with special consideration of age and BMI starting position.Breast cancer, ovarial cancer
DRKS00000781apharm GmbH1,500
Completed
Phase 3
A clinical Trial in patients with Vernal Keratoconjunctivitis. Clinical trial is to study efficacy, safety and tolerability of Tacrolimus Ophthalmic Suspension in comparison to Cyclosporine eye drops (reference product).
CTRI/2010/091/001456Ajanta Pharma Ltd200
Completed
Phase 3
result of vitimelin tablet and vitimelin oil in vitiligoHealth Condition 1: L80- Vitiligo
CTRI/2021/04/033014DrVasishths Ayuremedies30
Completed
Phase 2
A study for Under eye dark circles
CTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32